Heterogeneity of 5‐hydroxytryptamine receptors in the rat uterus and stomach strip
暂无分享,去创建一个
[1] J. Leysen,et al. KETANSERIN: A SELECTIVE ANTAGONIST OF 5-HT2 SEROTONINERGIC RECEPTORS , 1983, The Lancet.
[2] J. Millar,et al. MECHANISM OF ACTION OF KETANSERIN , 1982, The Lancet.
[3] G. P. Levy,et al. EVIDENCE FOR TWO TYPES OF EXCITATORY RECEPTOR FOR 5‐HYDROXYTRYPTAMINE IN DOG ISOLATED VASCULATURE , 1980, British journal of pharmacology.
[4] D. Rodbard,et al. Multi-subsite receptors for multivalent ligands. Application to drugs, hormones, and neurotransmitters. , 1979, Molecular pharmacology.
[5] D. Burleigh. Selectivity of bethanechol on muscarinic receptors , 1978, The Journal of pharmacy and pharmacology.
[6] R. Glennon,et al. Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues. , 1978, Journal of medicinal chemistry.
[7] M. Samir Amer,et al. Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure--activity relationships, and possible role in drug development. , 1975, Journal of pharmaceutical sciences.
[8] E. Domino. Discussion on Pharmacological Features of Trazodone , 1974 .
[9] I. Bonta,et al. Receptors involved in the action of 5-HT and tryptamine on the isolated rat stomach fundus preparation. , 1974, European journal of pharmacology.
[10] I. Bonta,et al. Effect of mianserin, a potent anti-serotonin agent, on the isolated rat stomach fundus preparation. , 1974, European journal of pharmacology.
[11] T. Hökfelt,et al. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.
[12] T. Hökfelt,et al. Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. , 1969, European journal of pharmacology.
[13] B. Silvestrini,et al. Pharmacological properties of AF 1161, a new psychotropic drug. , 1968, International journal of neuropharmacology.
[14] J. Offermeier,et al. Serotonin. I. receptors involved in its action. , 1966, Archives internationales de pharmacodynamie et de therapie.
[15] E. S. Johnson,et al. THE SITE OF THE 5-HYDROXYTRYPTAMINE RECEPTOR ON THE INTRAMURAL NERVOUS PLEXUS OF THE GUINEA-PIG ISOLATED ILEUM. , 1963, British journal of pharmacology and chemotherapy.
[16] Van Rossum Jm. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. , 1963 .
[17] J. V. van Rossum. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. , 1963, Archives internationales de pharmacodynamie et de therapie.
[18] D. Maxwell,et al. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo. , 1961, British journal of pharmacology and chemotherapy.
[19] J. Vane. A SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE , 1997, British journal of pharmacology and chemotherapy.
[20] J. Gaddum,et al. TWO KINDS OF TRYPTAMINE RECEPTOR , 1997, British journal of pharmacology and chemotherapy.
[21] H. Schild. Drug antagonism and pAx. , 1957, Pharmacological reviews.
[22] J. Mongar,et al. Improved automatic apparatus for pharmacological assays on isolated preparations. , 1954, British journal of pharmacology and chemotherapy.
[23] H. Schild. pA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISM , 1997, British journal of pharmacology and chemotherapy.